Bhumsuk Keam

4PUBLICATIONS
20CO-AUTHORS
Tumour immunologyMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 05, 2026
Resistance to anti-PD-1 immunotherapy for stage III and IV melanoma: a global chart review study.

Elizabeth M Gaughan, Miso Kim, Ignacio Mendez

|Mar 06, 2025
Cell-intrinsic PD-L1 signaling drives immunosuppression by myeloid-derived suppressor cells through IL-6/Jak/Stat3 in PD-L1-high lung cancer.

Hyein Jeong, Jaemoon Koh, Sehui Kim

|Feb 26, 2022
Influence of tumor mutational burden, inflammatory gene expression profile, and PD-L1 expression on response to pembrolizumab in head and neck squamous cell carcinoma.

Robert I Haddad, Tanguy Y Seiwert, Laura Q M Chow

|Aug 25, 2020
Anti-tumor effects of NK cells and anti-PD-L1 antibody with antibody-dependent cellular cytotoxicity in PD-L1-positive cancer cell lines.

Ji-Eun Park, Seong-Eun Kim, Bhumsuk Keam

Pageof 1

Frequent Collaborators

1 joint publications

Robert I Haddad

1 joint publications

Tanguy Y Seiwert

1 joint publications

Hyunseok Kang

1 joint publications

Yoon Kyung Jeon